The advertisement promotes Eliquis, highlighting important safety information and warnings related to its use, particularly regarding the risks associated with premature discontinuation.
Creative Information
| CID: | 20cfdacd-be85-41a8-be6e-f74b60fd424d |
| CRID: | 89_219387 |
| Domain: | eliquis.com |
| Seat: | DInt |
| Size: | 728x90 |
| Bid: | $1.50 |
| Timestamp: | 11/17/2025, 6:03:32 PM |
| Declared IAB Categories: |
Analysis
5 succeeded(100% complete)
| Task | Status | Last Updated | Duration | Actions |
|---|---|---|---|---|
| ad_analysis | success | 11/17/2025, 7:37:27 PM | 4.58s | |
| adomain_analysis | success | 11/17/2025, 7:37:09 PM | 5.26s | |
| adomain_capture | success | 11/17/2025, 7:37:03 PM | 0.20s | |
| ad_render | success | 11/17/2025, 7:37:22 PM | 17.86s | |
| brand_mapping | success | 11/17/2025, 6:03:32 PM | 0.14s | |
Analysis Results
| Size: | 728x90 | ||||||||||||||||||||||
| Data Transferred: | 1578.39 KB | ||||||||||||||||||||||
| Render Time: | 9.14 Seconds | ||||||||||||||||||||||
| Creative Inferred IAB Categories: |
| ||||||||||||||||||||||
| Creative Inferred IAB Ad Products: |
| ||||||||||||||||||||||
| Domain Inferred IAB Categories: |
| ||||||||||||||||||||||
| Domain Inferred IAB Ad Products: |
| ||||||||||||||||||||||
| Total Ad Size: | 1578.39 KB | ||||||||||||||||||||||
| Requests Made: |
|
Advertiser Domain

Ad Preview
Raw Ad Markup
<span id='deepintent_wrapper_0662bb1a-0d88-47b9-9fcc-87fbcf4d8a58' onclick=DeepIntentExecuteClicks('')><div style='display:inline-block;position:relative;height:90px'><script type='text/javascript'>document.addEventListener('DOMContentLoaded',function(){setTimeout(function(){new Image().src='https://useast-beacon.deepintent.com/vi?impid=09d418d4-a0a3-fa27-fa4d-948f42931696&spanlen='+ (document.getElementById('deepintent_wrapper_span_b-7b6f-5c4e-8ad6-b35ed34973aa').innerHTML.length) + '&spanelemcnt=' + (document.getElementById('deepintent_wrapper_span_b-7b6f-5c4e-8ad6-b35ed34973aa').getElementsByTagName('*').length);},3000)});</script><span id='deepintent_wrapper_span_b-7b6f-5c4e-8ad6-b35ed34973aa'><ins class='dcmads' style='display:inline-block;width:728px;height:90px' data-dcm-placement='N2123577.3219362APEXDEALS/B32886535.422562195' data-dcm-rendering-mode='script' data-dcm-landing-page-escapes='2' data-dcm-click-tracker='https://useast-beacon.deepintent.com/click/09d418d4-a0a3-fa27-fa4d-948f42931696?ts=1762992990995&wp=1.5&loc=1&r=' data-dcm-https-only data-dcm-api-frameworks='[APIFRAMEWORKS]' data-dcm-omid-partner='[OMIDPARTNER]' data-dcm-gdpr-applies='gdpr=${GDPR}' data-dcm-gdpr-consent='gdpr_consent=${GDPR_CONSENT_755}' data-dcm-addtl-consent='addtl_consent=${ADDTL_CONSENT}' data-dcm-ltd='false' data-dcm-resettable-device-id='' data-dcm-app-id='' data-dcm-param-dvs1='1' data-dcm-param-dvs2='${SOURCE_URL_ENC}' data-dcm-param-dvs3='214780' data-dcm-param-dvs4='09d418d4-a0a3-fa27-fa4d-948f42931696' data-dcm-param-dvs5='1' data-dcm-param-dvs6='103' data-dcm-param-dvs7='${BUNDLE_ID}' data-dcm-param-dvs8='219387' data-dcm-param-dvs9='${INSERTION_ORDER_ID}' data-dcm-param-dvs10='8797' data-dcm-param-dvs11='${UNIVERSAL_SITE_ID}' data-dcm-param-dvs12='${EXCHANGE_ID}' data-dcm-param-dvs13='1404354615' data-dcm-param-dvs14='1404354615' data-dcm-param-dvs15='${INVENTORY_SOURCE_EXTERNAL_ID}'> <script src='https://www.googletagservices.com/dcm/dcmads.js'></script></ins></span><script src="https://cdn.doubleverify.com/dvtp_src.js?ctx=20515845&cmp=DV973873&sid=deepintent&plc=deepintent_im_disp_js&adsrv=0&advid=3891363&ppid=118&dvtagver=6.1.src&aufilter1=IM&autt=1&auevent=09d418d4-a0a3-fa27-fa4d-948f42931696&aubndl=&pltfrm=10035&auip=50.103.82.7&DVPX_PP_AUCTION_UA=Mozilla%2F5.0+%28Macintosh%3B+Intel+Mac+OS+X+10_15_7%29+AppleWebKit%2F537.36+%28KHTML%2C+like+Gecko%29+Chrome%2F142.0.0.0+Safari%2F537.36&turl=https%3A%2F%2Fwww.inspirethemom.com%2F100-objects-that-start-with-q%2F" type="text/javascript"></script><div id='aeopt' style='position:absolute;z-index:9010;background-color:#CCCCCCCC;top:0;right:0;border-radius:0 0 0 5px;'><div id='aeopti' style='display:block;'><a href='https://www.deepintent.com/adchoices?payload=di_fac8073ba14d42e59deae%2C1%2C3b2a51b3-9799-469a-8b41-725e56badbb1%2C2%2C9c6fded52db40d78bcb0970d8af476cb%2C3%2C50.103.82.7%2C4%2Ceb96dd03-63e0-4c06-bff4-806d2e7d5103%2C135%2Chc_a1d161dc0cddd1b5e470bfc29070a490%2C7%2C790ff590eda47ff3aa297eb6af20a32a0d499601%2C8%2C2b039a62e5355a3e3ca0843593aca07df65983dad497b0fc8d072033d8aec323%2C9%2CAFD247B06531AB159D46FC699579B1355151E6B9881E103D9BCD5F66E8A49616%2C10%2CdZInxDK5OTL2QHYSHQIAJ1cx2isAdUFlgqLxbM98fSU%3D%2C11%2CLV5F00KUSAGYJSF7MAZNAPV22QDADYN6WGRY%2C12%2CEDI_s5O38tOZ6HFa17w6IQQ6NktKYslclw88skU0cpr3%252FJjPKiIjWbRKLzhga3sd5M9v%2C14%2CEH_H4lztV583zJoHqeIV20nG8WTbs5vrzHzZl%252FcjczZHf2qYd%252F738O1Jil2zFdNCPE4%2C15%2CXY13641QSThy7pfX2bUYxZbvWYG0h3JR3VcLexhqKQ2r_hV5Q%2C112%2CTH_334493876%2C121%2C64ef6312b1cbcf38aa9eada3d1dea68b' target='_blank' style='display:block;padding:1px 2px 1px 5px;'><img src='https://cdn.deepintent.com/adchoices/di-adchoices.png' alt='AdChoices' border='0' width='13' height='13' style='display:block;'></a></div></div></div></span><script type='text/javascript'>window.DeepIntentExecuteClicks=window.DeepIntentExecuteClicks||function(e){if(e)for(var n=e.split(','),t=0;t<n.length;t++)if(n[t])(new Image).src=n[t]};</script><noscript><img src='https://useast-beacon.deepintent.com/impression/09d418d4-a0a3-fa27-fa4d-948f42931696?ts=1762992990995&wp=1.5' height='0px' width='0px' style='display:none' referrerpolicy='no-referrer-when-downgrade'></noscript><script type="text/javascript">(function(){var r;try{r=window.location.ancestorOrigins[window.location.ancestorOrigins.length-1];}catch(e){}new Image().src='https://useast-beacon.deepintent.com/impression/09d418d4-a0a3-fa27-fa4d-948f42931696?ts=1762992990995&wp=1.5'+((typeof r==='string')?'&rf='+r:'');})();</script><iframe src='https://cdn.deepintent.com/syncpixel.html?_di_cfg=a' width='0' height='0' style='display:none;'></iframe>Creatives
